P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: POOLED DATA FROM PHASE III TRIALS

Autor: Jacobson, I.M., Jensen, D.M., Dieterich, D., Sarrazin, C., Foster, G.R., Yoshida, E.M., Nelson, M., Ingiliz, P., Soriano, V., Cooper, C., Stern, J.O., Quinson, A.-M., Kukolj, G., Scherer, J., Drulak, M., Gallivan, J.-P., Schobelock, M., Ferenci, P.
Zdroj: In Journal of Hepatology April 2014 60(1) Supplement:S457-S457
Databáze: ScienceDirect